Optimization of a Nanomedicine-Based Silicon Phthalocyanine 4 Photodynamic Therapy (Pc 4-PDT) Strategy for Targeted Treatment of EGFR-Overexpressing Cancers-Reference-Cited by-同舟云学术

Optimization of a Nanomedicine-Based Silicon Phthalocyanine 4 Photodynamic Therapy (Pc 4-PDT) Strategy for Targeted Treatment of EGFR-Overexpressing Cancers

Published:2012-07-19 Issue:8 Volume:9 Page:2331-2338
ISSN:1543-8384
Container-title:Molecular Pharmaceutics
language:en
Short-container-title:Mol. Pharmaceutics

Author:

Master Alyssa M.¹,Livingston Megan¹,Oleinick Nancy L.²³,Sen Gupta Anirban¹³

Affiliation:

1. Department of Biomedical Engineering, Case Western Reserve University, 2071 Martin Luther King Drive, Cleveland, Ohio 44106, United States

2. Department of Radiation Oncology, Case Western Reserve University, 10900 Euclid Avenue, Cleveland, Ohio 44106, United States

3. Case Comprehensive Cancer Center, Case Western Reserve University, 11100 Euclid Avenue, Cleveland, Ohio 44106, United States

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Pharmaceutical Science,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/mp300256e

Reference46 articles.

1. Future of oncologic photodynamic therapy

2. Photodynamic therapy (PDT): A short review on cellular mechanisms and cancer research applications for PDT

3. Targeted Optical Imaging and Photodynamic Therapy

4. Targeted photodynamic therapy – a promising strategy of tumor treatment

5. Targeted photodynamic therapy

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Photosensitizers in photodynamic therapy: An advancement in cancer treatment;Results in Chemistry;2024-08

2. Nanobody-mediated targeting of zinc phthalocyanine with polymer micelles as nanocarriers;International Journal of Pharmaceutics;2024-04

3. Fluorescence and photothermal dual-readout phthalocyanine-fluorescein conjugate for detection and photothermal sterilization of anaerobic bacteria;Sensors and Actuators B: Chemical;2023-10

4. Amphiphilic Protoporphyrin IX Derivatives as New Photosensitizing Agents for the Improvement of Photodynamic Therapy;Biomedicines;2022-02-10

5. EGFR-Targeted Photodynamic Therapy;Pharmaceutics;2022-01-20